High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis

Clinical Biochemistry

Volumn 49, Issue 7-8, 2016, Pages 636-642

  Zhou, Yongjing ^a   Wei, Feifei ^a   Fan, Yu ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Meta analysis; Nonalcoholic fatty liver disease; Serum uric acid

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; EMBASE; EVALUATION STUDY; HAZARD RATIO; HIGH RISK POPULATION; HUMAN; INCIDENCE; MEDLINE; META ANALYSIS; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; WANFANG DATABASE; BLOOD; FEMALE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE;

BIOMARKERS; FEMALE; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; URIC ACID;

EID: 84954285517     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.12.010     Document Type: Review

References (50)

1. Bellentani S., Scaglioni F., Marino M., Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 2010, 28:155-161.
2. Williams C.D., Stengel J., Asike M.I., Torres D.M., Shaw J., Contreras M., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
3. Fan J.G., Farrell G.C. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009, 50:204-210.
4. Starley B.Q., Calcagno C.J., Harrison S.A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010, 51:1820-1832.
5. Socha P., Wierzbicka A., Neuhoff-Murawska J., Wlodarek D., Podlesny J., Socha J. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Rocz. Panstw. Zakl. Hig. 2007, 58:129-137.
6. Petta S., Muratore C., Craxi A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig. Liver Dis. 2009, 41:615-625.
7. Hediger M.A., Johnson R.J., Miyazaki H., Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005, 20:125-133.
8. Puig J.G., Martinez M.A. Hyperuricemia, gout and the metabolic syndrome. Curr. Opin. Rheumatol. 2008, 20:187-191.
9. Yoo T.W., Sung K.C., Shin H.S., Kim B.J., Kim B.S., Kang J.H., et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ. J. 2005, 69:928-933.
10. Billiet L., Doaty S., Katz J.D., Velasquez M.T. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014, 2014:852954.
11. Hamaguchi M., Kojima T., Takeda N., Nakagawa T., Taniguchi H., Fujii K., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005, 143:722-728.
12. Lv Q., Meng X.F., He F.F., Chen S., Su H., Xiong J., et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS ONE 2013, 8.
13. Viazzi F., Leoncini G., Vercelli M., Deferrari G., Pontremoli R. Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the magic study. Diabetes Care 2011, 34:126-128.
14. Krishnan E., Pandya B.J., Chung L., Hariri A., Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am. J. Epidemiol. 2012, 176:108-116.
15. Talaat K.M. el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am. J. Nephrol. 2007, 27:435-440.
16. Nashar K., Fried L.F. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?. Adv Chronic Kidney Dis. 2012, 19:386-391.
17. Carbone F., Montecucco F., Mach F., Pontremoli R., Viazzi F. The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. Thromb. Haemost. 2013, 110:940-958.
18. Lee J.W., Cho Y.K., Ryan M., Kim H., Lee S.W., Chang E., et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010, 4:378-383.
19. Yamada T., Suzuki S., Fukatsu M., Wada T., Yoshida T., Joh T. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastroenterol. Belg. 2010, 73:12-17.
20. Xu C., Yu C., Xu L., Miao M., Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS ONE 2010, 5.
21. Liang G.W., Xu X., Liu Y., Liu L., Zhao N. Association between serum uric acid and nonalcoholic fatty liver disease in Beijng adults. J Med Res. 2011, 40:66-69.
22. Ryu S., Chang Y., Kim S.G., Cho J., Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism 2011, 60:860-866.
23. Hwang I.C., Suh S.Y., Suh A.R., Ahn H.Y. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J. Korean Med. Sci. 2011, 26:386-391.
24. Xie Y., Wang M., Zhang Y., Zhang S., Tan A., Gao Y., et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS ONE 2013, 8.
25. Cai W., Wu X., Zhang B., Miao L., Sun Y.P., Zou Y., et al. Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. Arq Bras Endocrinol Metabol. 2013, 57:617-622.
26. Sirota J.C., McFann K., Targher G., Johnson R.J., Chonchol M., Jalal D.I. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the united states: liver ultrasound data from the national health and nutrition examination survey. Metabolism 2013, 62:392-399.
27. Shih M.H., Lazo M., Liu S.H., Bonekamp S., Hernaez R., Clark J.M. Association between serum uric acid and nonalcoholic fatty liver disease in the us population. J. Formos. Med. Assoc. 2013, 113. 10.1016/j.jfma.2012.11.014.
28. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. J. Am. Med. Assoc. 2000, 283:2008-2012.
29. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
30. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. Ann. Intern. Med. 2007, 147:573-577.
31. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
32. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
33. Kim S.Y., Guevara J.P., Kim K.M., Choi H.K., Heitjan D.F., Albert D.A. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010, 62:170-180.
34. Gayoso-Diz P., Otero-Gonzalez A., Rodriguez-Alvarez M.X., Gude F., Garcia F., De Francisco A., et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: Epirce cross-sectional study. BMC Endocr. Disord. 2013, 13:47.
35. Li Y., Xu C., Yu C., Xu L., Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J. Hepatol. 2009, 50:1029-1034.
36. Lonardo A., Loria P., Leonardi F., Borsatti A., Neri P., Pulvirenti M., et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. a case-control study. Dig. Liver Dis. 2002, 34:204-211.
37. Petta S., Camma C., Cabibi D., Di Marco V., Craxi A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2011, 34:757-766.
38. Sertoglu E., Ercin C.N., Celebi G., Gurel H., Kayadibi H., Genc H., et al. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin. Biochem. 2014, 47:383-388.
39. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005, 67:1739-1742.
40. Lanaspa M.A., Sanchez-Lozada L.G., Choi Y.J., Cicerchi C., Kanbay M., Roncal-Jimenez C.A., et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012, 287:40732-40744.
41. Ucar F., Sezer S., Erdogan S., Akyol S., Armutcu F., Akyol O. The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis. Redox Rep. 2013, 18:127-133.
42. Tariq Z., Green C.J., Hodson L. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (nash)?. Liver Int. 2014, 34:e180-e190.
43. Wang M., Zhao D., Li G.W., Wang W., Liu J., Liu J., et al. Correlation between serum uric acid and insulin resistance. Zhonghua Yi Xue Za Zhi 2007, 87:3260-3263.
44. Ghaemi-Oskouie F., Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr. Rheumatol. Rep. 2011, 13:160-166.
45. Ruggiero C., Cherubini A., Ble A., Bos A.J., Maggio M., Dixit V.D., et al. Uric acid and inflammatory markers. Eur. Heart J. 2006, 27:1174-1181.
46. Asrih M., Jornayvaz F.R. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013, 218:R25-R36.
47. Lomonaco R., Ortiz-Lopez C., Orsak B., Webb A., Hardies J., Darland C., et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2012, 55:1389-1397.
48. Facchini F., Chen Y.D., Hollenbeck C.B., Reaven G.M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. J. Am. Med. Assoc. 1991, 266:3008-3011.
49. Hernaez R., Lazo M., Bonekamp S., Kamel I., Brancati F.L., Guallar E., et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011, 54:1082-1090.
50. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N. Engl. J. Med. 2008, 359:1811-1821.